Global Branded Generics Market Research Report 2017

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 108

Report ID: 117630

In this report, the global Branded Generics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Branded Generics in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Branded Generics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Valeant Pharmaceuticals International
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Alkylating Agents
Antimetabolites
Hormones
Anti-Hypertensive
Lipid Lowering Drugs
Anti-Depressants
Anti-Psychotics
Anti-Epileptics
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Branded Generics for each application, including
Oral
Parenteral
Topical
Other

Table of Contents

Global Branded Generics Market Research Report 2017
1 Branded Generics Market Overview
1.1 Product Overview and Scope of Branded Generics
1.2 Branded Generics Segment by Type (Product Category)
1.2.1 Global Branded Generics Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Branded Generics Production Market Share by Type (Product Category) in 2016
1.2.3 Alkylating Agents
1.2.4 Antimetabolites
1.2.5 Hormones
1.2.6 Anti-Hypertensive
1.2.7 Lipid Lowering Drugs
1.2.8 Anti-Depressants
1.2.9 Anti-Psychotics
1.2.10 Anti-Epileptics
1.2.11 Other
1.3 Global Branded Generics Segment by Application
1.3.1 Branded Generics Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.3.5 Other
1.4 Global Branded Generics Market by Region (2012-2022)
1.4.1 Global Branded Generics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Branded Generics (2012-2022)
1.5.1 Global Branded Generics Revenue Status and Outlook (2012-2022)
1.5.2 Global Branded Generics Capacity, Production Status and Outlook (2012-2022)

2 Global Branded Generics Market Competition by Manufacturers
2.1 Global Branded Generics Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Branded Generics Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Branded Generics Production and Share by Manufacturers (2012-2017)
2.2 Global Branded Generics Revenue and Share by Manufacturers (2012-2017)
2.3 Global Branded Generics Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Branded Generics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Branded Generics Market Competitive Situation and Trends
2.5.1 Branded Generics Market Concentration Rate
2.5.2 Branded Generics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Branded Generics Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Branded Generics Capacity and Market Share by Region (2012-2017)
3.2 Global Branded Generics Production and Market Share by Region (2012-2017)
3.3 Global Branded Generics Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Branded Generics Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Branded Generics Consumption by Region (2012-2017)
4.2 North America Branded Generics Production, Consumption, Export, Import (2012-2017)
4.3 Europe Branded Generics Production, Consumption, Export, Import (2012-2017)
4.4 China Branded Generics Production, Consumption, Export, Import (2012-2017)
4.5 Japan Branded Generics Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Branded Generics Production, Consumption, Export, Import (2012-2017)
4.7 India Branded Generics Production, Consumption, Export, Import (2012-2017)

5 Global Branded Generics Production, Revenue (Value), Price Trend by Type
5.1 Global Branded Generics Production and Market Share by Type (2012-2017)
5.2 Global Branded Generics Revenue and Market Share by Type (2012-2017)
5.3 Global Branded Generics Price by Type (2012-2017)
5.4 Global Branded Generics Production Growth by Type (2012-2017)

6 Global Branded Generics Market Analysis by Application
6.1 Global Branded Generics Consumption and Market Share by Application (2012-2017)
6.2 Global Branded Generics Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Branded Generics Manufacturers Profiles/Analysis
7.1 Mylan NV
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Branded Generics Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Mylan NV Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Novartis AG
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Branded Generics Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Novartis AG Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Eva Pharmaceutical Industries
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Branded Generics Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Eva Pharmaceutical Industries Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Pfizer
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Branded Generics Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Pfizer Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Sun Pharmaceutical Industries
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Branded Generics Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Sun Pharmaceutical Industries Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Aspen Pharmacare Holding
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Branded Generics Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Aspen Pharmacare Holding Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Abbott Laboratories
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Branded Generics Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Abbott Laboratories Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Valeant Pharmaceuticals International
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Branded Generics Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Valeant Pharmaceuticals International Branded Generics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview

8 Branded Generics Manufacturing Cost Analysis
8.1 Branded Generics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Branded Generics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Branded Generics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Branded Generics Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Branded Generics Market Forecast (2017-2022)
12.1 Global Branded Generics Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Branded Generics Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Branded Generics Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Branded Generics Price and Trend Forecast (2017-2022)
12.2 Global Branded Generics Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Branded Generics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Branded Generics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Branded Generics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Branded Generics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Branded Generics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Branded Generics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Branded Generics Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Branded Generics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer